REQUEST A DEMO
Total
USD $0.00
Search more companies

Dynapharm (M) Sdn Bhd (Malaysia)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Dynapharm (M) Sdn Bhd Profile Updated: January 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dynapharm (M) Sdn Bhd is a company based in Malaysia, with its head office in Perai. The enterprise operates in the Medicinal and Botanical Manufacturing industry. It was incorporated on December 18, 1980. In 2024, the company reported a net sales revenue increase of 9.48%. Its total assets grew by 5.57% over the same period. The net profit margin of Dynapharm (M) Sdn Bhd decreased by 0.95% in 2024.

Headquarters
2497, Mk.1,Lorong Perusahaan Baru 5,Kawasan Perusahaan Perai 3,
Perai; Penang; Postal Code: 13600

Contact Details: Purchase the Dynapharm (M) Sdn Bhd report to view the information.

Website: http://www.dynagroup.com.my

Basic Information
Registered Capital:
Purchase the Dynapharm (M) Sdn Bhd report to view the information.
Financial Auditors:
Purchase the Dynapharm (M) Sdn Bhd report to view the information.
Incorporation Date:
December 18, 1980
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Dynapharm (M) Sdn Bhd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
9.48%
Total operating revenue
9.48%
Operating Profit/Loss (EBIT)
0.04%
EBITDA
-22.04%
Net Profit/Loss for the Period
1.57%
Total Assets
5.57%
Total Equity
8.67%
Operating Profit Margin (ROS)
-1.58%
Net Profit Margin
-0.95%
Return on Equity (ROE)
-1.1%
Debt/Equity
0.87%
Quick Ratio
0.31%
Cash Ratio
0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?